Delisting risk
Nexalin Technology
Non-invasive brain-stimulation systems for clinical and physician-supervised home care.
$0.2679
After-hours close+0.01 (+5.81%)
At close$0.2532(−0.63%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.10 | −$0.11 | −10.0% |
| May 2026 | −$0.11 | −$0.11 | 0.0% |
| Mar 2026 | −$0.12 | −$0.13 | −8.3% |
| Nov 2025 | −$0.12 | −$0.13 | −8.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | −$0.10 | −$0.11 | −10.0% | $90.0K | $12.2K | −86.5% |
| May 8, 2026 | −$0.11 | −$0.11 | 0.0% | $15.0K | $15.0K | −0.3% |
| Mar 25, 2026 | −$0.12 | −$0.13 | −8.3% | $80.0K | $172.0K | +115.0% |
| Nov 14, 2025 | −$0.12 | −$0.13 | −8.3% | $40.0K | $18.1K | −54.6% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 14, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 10, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 10, 2023 | ||||||
| Mar 27, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Jun 30, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Dec 31, 2021 | ||||||
| Sep 30, 2021 | ||||||
| Jun 30, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||